
Alexander Ditchfield
Managing Director
New York
Alexander Ditchfield is a Managing Director based in New York. Clients for whom he has advised on transactions include Aterian Investment Partners, CHS, CITIC Capital, Kerry, Littlejohn, On Semi, MacLean-Fogg, Molex, and Pfizer, among others.
Prior to moving to New York in 2016, he worked in BDA’s Shanghai and Hong Kong offices for seven years.
Before joining BDA, he worked on policy for the European Union’s SWITCH-Asia and Asia Invest projects, promoting sustainable development, trade and investment flow between EU and Asia, at the EU Project Incubation (EUPIC) Centre in Chengdu, China. He graduated with a BSc in Economics from Cardiff University in the UK. He speaks Mandarin and English.
Recent transactions
a portfolio company of
has been sold to
2023
divested Niigata fab to
Sangyo Sosei and Fukuoka Capital
2022
acquired by
a portfolio company of
2022
has been acquired by
2022
divested ASG Print to
and
2021
has been acquired by
2021
divested China phenolic resins plant to
2021
divested to
a portfolio company of
2020
Presswerk Krefeld a portfolio company of
has been acquired by
2017
Equity capital raise and new Asian partnerships
2016
Divested CHS Ningbo Protein Foods to Shandong Wonderful
2016
Agreed to Divest Tri-Wall Holdings to Rengo
2016
Divested DeltaTech Controls to Sensata Technologies
2014
Divested Hercules Tire to American Tire Distributors
2014
Divested KDM to Superior Capital Partners / Nelson-Miller
2012